Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiac Action Potential

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial intelligence electrocardiography for left ventricular systolic dysfunction demonstrates preserved performance across demographic training imbalances.

European heart journal. Digital health·2026

Same author

The present and the future of risk stratification for and prevention of sudden cardiac death: A Heart Rhythm Society think tank meeting.

Heart rhythm·2026

Same author

Artificial Intelligence-Enhanced Electrocardiography and Health Records to Predict Cardiac Arrest.

JACC. Advances·2026

Same author

Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future Directions.

The American journal of cardiology·2026

Same author

Personalized artificial intelligence based left ventricular ejection fraction and systolic dysfunction assessment.

NPJ digital medicine·2026

Same author

Artificial Intelligence Powered Wearable and Portable Devices for Remote Cardiac Care and Population Health.

Current cardiology reports·2026

Same journal

Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care.

Heart failure clinics·2026

Same journal

Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?

Heart failure clinics·2026

Same journal

Recent Advances in Pulmonary Hypertension Management.

Heart failure clinics·2026

Same journal

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.

Heart failure clinics·2026

Same journal

Portopulmonary Hypertension: Current Perspectives.

Heart failure clinics·2026

Same journal

Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.

Heart failure clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Cardiac resynchronization therapy: past, present, and future.

Neal A Chatterjee¹, Jagmeet P Singh²

¹Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

Heart Failure Clinics

|April 4, 2015

Summary

This summary is machine-generated.

Cardiac resynchronization therapy (CRT) improves outcomes for heart failure patients with electrical dyssynchrony. However, some patients do not respond, necessitating strategies to optimize CRT effectiveness and address future challenges.

Keywords:

Biventricular pacing Cardiac resynchronization therapy Electrical dyssynchrony Heart failure

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Experiment Videos

Last Updated: Apr 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Area of Science:

Cardiology
Medical Devices
Heart Failure Management

Background:

Cardiac resynchronization therapy (CRT), also known as biventricular pacing, is a standard treatment for symptomatic heart failure (HF).
CRT is indicated for patients with reduced left ventricular (LV) function and significant electrical dyssynchrony.
Despite its benefits, a notable portion of patients do not respond to CRT, highlighting a need for further research and optimization strategies.

Purpose of the Study:

To review the electrical and physiological basis of biventricular pacing.
To summarize key clinical trials evaluating CRT efficacy.
To discuss methods for enhancing patient response to CRT and outline future challenges.

Main Methods:

Literature review of landmark clinical trials and physiological studies.
Analysis of strategies for optimizing CRT response.
Discussion of future directions in CRT delivery and patient care.

Main Results:

CRT has demonstrated significant improvements in morbidity and mortality in selected HF populations.
Understanding the electrical and physiological rationale is crucial for effective CRT implementation.
Various strategies exist to optimize CRT response, though nonresponse remains a clinical challenge.

Conclusions:

CRT is an established therapy for specific heart failure patients, improving clinical outcomes.
Optimizing CRT response requires a multifaceted approach, addressing patient selection, device programming, and lead placement.
Future research should focus on improving CRT delivery, patient selection, and long-term management to maximize benefits and minimize nonresponse.